Skip to content

AURORE LAFOSSE PLASTIC SURGERY

Active
Private limited companyfounded 2018active for 8 yearsDrève Richelle 161, 1410 Waterloo, BelgiumKBO/BCE: BE 0698.705.351

From the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

AURORE LAFOSSE PLASTIC SURGERY has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €358,491 and a net result of €74,226. Equity has been growing by about 27% per year since 2019. Its solvency ranks better than 68% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 21-06-2018 Normal situation
Registered office
244 active companies are registered at this address 2 started in the 12 months before. Source: KBO register, as of 1 November 2026.
Activity
Specialist medical practice NACE 86220
Establishment unit
2.277.485.269 1410 Waterloo, since 01-07-2018
Financial year end
30 September
Peppol
Reachable since 10-12-2025

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts to 30-09-2025
Gross margin
€234,939
▼ 19.2%
Turnover
≈ €440,000
estimated
Profit
€74,226
▼ 43.2%
Equity
€358,491
▲ 26.1%
Total assets
€458,452
▲ 3.7%
Filed on 21-04-2026, 9 days before the deadlinePDF
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.67, cash €79,924Figures for financial year 2025 (filed on 21-04-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 51% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+11
equity 78.2% of total assets
Liquidity 64-15
short-term debt 21.8% · cash 17.4%
Profitability 62-21
return on assets 16.2%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: 0.1%▲ +0.1 percentage points vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026highest value 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.67 (2.38 in 2024), above the usual 1.5. Short-term debt is 21.8% and cash 17.4% of total assets. 21.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 43% on liquidity, 10% on profitability and 69% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Liquidity: current ratio 2.67, cash €79,924
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 21-04-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 21-04-2026, 9 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
9 days early
2024
21 days early
2023
26 days early
2022
16 days early
2021
33 days early
2020
29 days early
2019
22 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 22 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 9 April (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end01-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Result fell in 2025from €130,666 to €74,226 ▼ 43.2% View
  • Positive: Always filed on timeaccounts within the deadline every year 7 years View
  • Positive: 7 profitable years in a rowprofit 2025: €74,226 7 years View

Comparable companies

These companies have the same main activity as AURORE LAFOSSE PLASTIC SURGERY: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €433,000 and €503,000, founded between 2018 and 2019.

CompanyTotal assetsGross margin
AURORE LAFOSSE PLASTIC SURGERY Waterloo€458,452€234,939
Docteur Donatienne Taylor Oncologie Grez-Doiceau€444,977€230,193
Docteur Andreevscaia Olga - Dermatologue Namur€433,324€244,668
Dr. Deseyne Sarah Nazareth-De Pinte€500,358€235,391
Dr. Mertens Katleen Zonhoven€438,688€252,555
PGA Remicourt€502,619€235,423
Dr. Dedovic Amintas Roeselare€474,248€221,863
Full comparison

Documents

Annual accounts at the NBB

All 7 annual accounts

Articles and registers

Key facts about AURORE LAFOSSE PLASTIC SURGERY

What is the company number of AURORE LAFOSSE PLASTIC SURGERY?
The company number of AURORE LAFOSSE PLASTIC SURGERY is 0698.705.351. The VAT number is the same number with BE in front: BE 0698.705.351.
Where is AURORE LAFOSSE PLASTIC SURGERY based?
The registered office is at Drève Richelle 161, 1410 Waterloo.Company details
What does AURORE LAFOSSE PLASTIC SURGERY do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of AURORE LAFOSSE PLASTIC SURGERY?
The legal form of AURORE LAFOSSE PLASTIC SURGERY is Private limited company (BV).
When was AURORE LAFOSSE PLASTIC SURGERY founded?
AURORE LAFOSSE PLASTIC SURGERY was founded on 21-06-2018.
Is AURORE LAFOSSE PLASTIC SURGERY still active?
Yes, AURORE LAFOSSE PLASTIC SURGERY is an active enterprise in the KBO register.
How many employees does AURORE LAFOSSE PLASTIC SURGERY have?
AURORE LAFOSSE PLASTIC SURGERY had an average of 0.5 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
What is the turnover of AURORE LAFOSSE PLASTIC SURGERY?
The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €234,939 and 43 comparable companies (NACE 86220). It probably lies between €370,000 and €580,000.
Is AURORE LAFOSSE PLASTIC SURGERY profitable?
In financial year 2025, AURORE LAFOSSE PLASTIC SURGERY made a profit of €74,226.
Where can I find the annual accounts of AURORE LAFOSSE PLASTIC SURGERY?
AURORE LAFOSSE PLASTIC SURGERY filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of AURORE LAFOSSE PLASTIC SURGERY due?
AURORE LAFOSSE PLASTIC SURGERY must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.